Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0A3SX
|
|||
| Former ID |
DIB008588
|
|||
| Drug Name |
PTHr pepducins
|
|||
| Synonyms |
PTHr pepducins (endocrine/metabolic disorders); PTHr pepducins (endocrine/metabolic disorders), Anchor Therapeutics; Parathyroid hormone receptor-modulating pepducins (lipopeptide, endocrine/metabolic disorders), Anchor Therapeutics
Click to Show/Hide
|
|||
| Indication | Endocrine disease [ICD-11: 5B3Z; ICD-10: E20-E35] | Investigative | [1] | |
| Company |
Anchor Therapeutics Inc
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Parathyroid hormone receptor (PTH2R) | Target Info | Modulator | [1] |
| KEGG Pathway | Neuroactive ligand-receptor interaction | |||
| Reactome | Class B/2 (Secretin family receptors) | |||
| G alpha (s) signalling events | ||||
| WikiPathways | GPCRs, Class B Secretin-like | |||
| GPCR ligand binding | ||||
| GPCR downstream signaling | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 332). | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.